{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T01:59:42Z","timestamp":1791683982790,"version":"4.3.4"},"reference-count":121,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Research and Graduate Studies at King Khalid University","award":["RGP2\/488\/46"],"award-info":[{"award-number":["RGP2\/488\/46"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Respiratory syncytial virus (RSV) continues as the major cause of acute lower respiratory tract infections in children around the world, and its substantial morbidity, particularly among infants and high-risk children, poses a significant burden on healthcare systems worldwide. RSV infections occur as a spectrum, ranging from mild upper respiratory symptoms to severe bronchiolitis and pneumonia, and the number of infections shows seasonal variations in different latitudes, as well as lasting impacts, reflecting the COVID-19 pandemic. The pathogenesis of the virus involves epithelial cell invasion and\/or fusion to form syncytia, along with exaggerated immune-mediated responses. Disease severity is known to depend on viral load, strain variation, and host immune immaturity. Severe RSV infection during infancy is notably linked with long-term respiratory sequelae such as recurrent wheezing and asthma. Diagnosis is based on clinical suspicion and laboratory confirmation using rapid antigen testing or nucleic acid amplification tests, namely PCR. Non-pharmaceutical interventions, maternal vaccination, and prophylaxis with monoclonal antibodies, e.g., palivizumab and nirsevimab, a newly introduced long-acting agent, are efficient protective and preventive measures. Treatment is still, for the most part, supportive in nature and focuses on oxygen supplementation, hydration, and respiratory support for patients with more severe disease courses; however, the development of immunoprophylaxis and vaccine candidates shows promise for reducing the global burden of RSV.<\/jats:p>","DOI":"10.3390\/jcm14113880","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:21:49Z","timestamp":1748859709000},"page":"3880","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9858-9789","authenticated-orcid":false,"given":"Ali Alsuheel","family":"Asseri","sequence":"first","affiliation":[{"name":"Department of Child Health, College of Medicine, King Khalid University, Abha 62529, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The Burden of Respiratory Syncytial Virus Infection in Young Children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13052-021-01148-8","article-title":"Epidemiology and prevention of respiratory syncytial virus infections in children in Italy","volume":"47","author":"Azzari","year":"2021","journal-title":"Ital. J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40121-020-00387-2","article-title":"Current State of Respiratory Syncytial Virus Disease and Management","volume":"10","author":"Chatterjee","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_6","first-page":"S120","article-title":"New advances in RSV: Is prevention attainable?","volume":"60","author":"Zar","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Esposito, S., Abu Raya, B., Baraldi, E., Flanagan, K., Martinon Torres, F., Tsolia, M., and Zielen, S. (2022). RSV Prevention in All Infants: Which Is the Most Preferable Strategy?. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.880368"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.vaccine.2023.03.024","article-title":"Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe","volume":"41","author":"Mao","year":"2023","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s12098-023-04613-w","article-title":"Respiratory Syncytial Virus Infection: An Update","volume":"90","author":"Soni","year":"2023","journal-title":"Indian J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40121-017-0151-4","article-title":"The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood","volume":"6","author":"Fauroux","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/irv.12726","article-title":"Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance","volume":"14","author":"Chadha","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","article-title":"Seasonality of Respiratory Syncytial Virus\u2014United States, 2017\u20132023","volume":"72","author":"Hamid","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bell, C., Goss, M., Norton, D., Barlow, S., Temte, E., He, C., Hamer, C., Walters, S., Sabry, A., and Johnson, K. (2024). Descriptive Epidemiology of Pathogens Associated with Acute Respiratory Infection in a Community-Based Study of K-12 School Children (2015\u20132023). Pathogens, 13.","DOI":"10.3390\/pathogens13040340"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.intimp.2008.03.012","article-title":"Host immunity during RSV pathogenesis","volume":"8","author":"Bueno","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Carvajal, J.J., Avellaneda, A.M., Salazar-Ardiles, C., Maya, J.E., Kalergis, A.M., and Lay, M.K. (2019). Host Components Contributing to Respiratory Syncytial Virus Pathogenesis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02152"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Piralla, A., Chen, Z., and Zaraket, H. (2023). An update on respiratory syncytial virus. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08730-x"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s10096-018-3289-4","article-title":"Human respiratory syncytial virus: Pathogenesis, immune responses, and current vaccine approaches","volume":"37","author":"Taleb","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/INF.0000000000002914","article-title":"Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection","volume":"40","author":"Mertz","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jaip.2020.11.016","article-title":"The Influence of Immune Immaturity on Outcome After Virus Infections","volume":"9","author":"Shaw","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40272-023-00606-6","article-title":"Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date","volume":"26","author":"Verwey","year":"2024","journal-title":"Paediatr. Drugs"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/0115733963267129230919091338","article-title":"Acute Bronchiolitis: The Less, the Better?","volume":"20","author":"Virgili","year":"2024","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15537\/smj.2021.42.4.20200769","article-title":"Saudi experts\u2019 recommendation for RSV prophylaxis in the era of COVID-19: Consensus from the Saudi Pediatric Pulmonology Association","volume":"42","author":"Alharbi","year":"2021","journal-title":"Saudi Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s12325-024-02798-w","article-title":"Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study","volume":"41","author":"Alharbi","year":"2024","journal-title":"Adv. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-92-22538","article-title":"Recovery of cytopathogenic agent from chimpanzees with coryza","volume":"92","author":"Blount","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/infdis\/jiaa751","article-title":"Risk Factors for Poor Outcome or Death in Young Children with Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis","volume":"226","author":"Shi","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5644\/ama2006-124.297","article-title":"RSV Lower Respiratory Tract Illness in Infants of Low- and Middle-income Countries","volume":"49","author":"Laudanno","year":"2020","journal-title":"Acta Med. Acad."},{"key":"ref_31","first-page":"e42563","article-title":"Impact of COVID-19 Pandemic on Respiratory Syncytial Virus (RSV) Prophylaxis Program: A Tertiary-Care Center Experience","volume":"15","author":"Kelabi","year":"2023","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107052","DOI":"10.1016\/j.ijid.2024.107052","article-title":"Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS)","volume":"144","author":"Caini","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lang, J.C. (2022). Use of mathematical modelling to assess respiratory syncytial virus epidemiology and interventions: A literature review. J. Math. Biol., 84.","DOI":"10.1007\/s00285-021-01706-y"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-2600(22)00414-3","article-title":"The burden of respiratory syncytial virus in healthy term-born infants in Europe: A prospective birth cohort study","volume":"11","author":"Wildenbeest","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/irv.12557","article-title":"Burden and epidemiology of influenza- and respiratory syncytial virus-associated severe acute respiratory illness hospitalization in Madagascar, 2011\u20132016","volume":"13","author":"Rabarison","year":"2019","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1007\/s12325-024-02954-2","article-title":"Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective","volume":"41","author":"Alzaabi","year":"2024","journal-title":"Adv. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e70077","DOI":"10.1111\/irv.70077","article-title":"Trends in Proportions of Respiratory Syncytial Virus Infections Among Reported Respiratory Tract Infection Cases in Children Aged 0 to 5 Years in Western Pacific and Southeast Asia Regions: A Systematic Review and Meta-Analysis","volume":"19","author":"Park","year":"2025","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_38","first-page":"2400178","article-title":"Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024","volume":"29","author":"Nielsen","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/infdis\/jiad188","article-title":"Burden of Respiratory Syncytial Virus in the European Union: Estimation of RSV-associated hospitalizations in children under 5 years","volume":"228","author":"Spreeuwenberg","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"020431","DOI":"10.7189\/jogh.09.020431","article-title":"Respiratory syncytial virus in the Western Pacific Region: A systematic review and meta-analysis","volume":"9","author":"Pangesti","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2021053537","DOI":"10.1542\/peds.2021-053537","article-title":"RSV Epidemiology in Australia Before and During COVID-19","volume":"149","author":"Saravanos","year":"2022","journal-title":"Pediatrics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41467-022-30485-3","article-title":"Off-season RSV epidemics in Australia after easing of COVID-19 restrictions","volume":"13","author":"Eden","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2445791","DOI":"10.1080\/07853890.2024.2445791","article-title":"Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia","volume":"57","author":"Asseri","year":"2025","journal-title":"Ann. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Reicherz, F., Vi\u00f1eta Paramo, M., Bone, J.N., Lavoie, A., Li, S., Golding, L., Jassem, A., Watts, A., Abu-Raya, B., and Lavoie, P.M. (2025). Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus Infections. J. Infect. Dis., jiaf101.","DOI":"10.1093\/infdis\/jiaf101"},{"key":"ref_45","first-page":"579","article-title":"RSV prophylaxis in premature infants","volume":"70","author":"Franco","year":"2018","journal-title":"Minerva Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"DiFranza, J.R., Masaquel, A., Barrett, A.M., Colosia, A.D., and Mahadevia, P.J. (2012). Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr., 12.","DOI":"10.1186\/1471-2431-12-81"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0038-1637752","article-title":"The Impact of RSV-Associated Respiratory Disease on Children in Asia","volume":"14","author":"Divarathne","year":"2019","journal-title":"J. Pediatr. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/infdis\/jir494","article-title":"Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children","volume":"204","author":"Bush","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/infdis\/jiac163","article-title":"Clinical and Viral Factors Associated with Disease Severity and Subsequent Wheezing in Infants with Respiratory Syncytial Virus Infection","volume":"226","author":"McGinley","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/infdis\/jiy655","article-title":"Viral Load Dynamics and Clinical Disease Severity in Infants with Respiratory Syncytial Virus Infection","volume":"219","author":"Thomas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2222.2004.1947.x","article-title":"Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis","volume":"34","author":"Goetghebuer","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/INF.0000000000001007","article-title":"Reduced Expression of HLA-DR on Monocytes During Severe Respiratory Syncytial Virus Infections","volume":"35","author":"Ahout","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bergeron, H.C., and Tripp, R.A. (2021). Immunopathology of RSV: An Updated Review. Viruses, 13.","DOI":"10.3390\/v13122478"},{"key":"ref_54","unstructured":"Salas, A., Pardo-Seco, J., Cebey-L\u00f3pez, M., G\u00f3mez-Carballa, A., Obando-Pacheco, P., Rivero-Calle, I., Curr\u00e1s-Tuala, M.J., Amigo, J., G\u00f3mez-Rial, J., and Martin\u00f3n-Torres, F. (2017). Whole Exome Sequencing reveals new candidate genes in host genomic susceptibility to Respiratory Syncytial Virus Disease. Sci. Rep., 7."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings","volume":"35","author":"Siegel","year":"2007","journal-title":"Am. J. Infect. Control."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"107196","DOI":"10.1016\/j.buildenv.2020.107196","article-title":"Trajectories of large respiratory droplets in indoor environment: A simplified approach","volume":"183","author":"Cheng","year":"2020","journal-title":"Build. Env."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Manti, S., Spoto, G., Nicotera, A.G., Di Rosa, G., and Piedimonte, G. (2023). Impact of respiratory viral infections during pregnancy on the neurological outcomes of the newborn: Current knowledge. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1320319"},{"key":"ref_58","first-page":"3","article-title":"Respiratory syncytial virus: Virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"King, T., Mejias, A., Ramilo, O., and Peeples, M.E. (2021). The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009469"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-020-2369-7","article-title":"IGF1R is an entry receptor for respiratory syncytial virus","volume":"583","author":"Griffiths","year":"2020","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.23736\/S0026-4946.18.05312-4","article-title":"Respiratory syncytial virus","volume":"70","author":"Pierangeli","year":"2018","journal-title":"Minerva Pediatr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/modpathol.3800725","article-title":"The Histopathology of Fatal Untreated Human Respiratory Syncytial Virus Infection","volume":"20","author":"Johnson","year":"2007","journal-title":"Mod. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.79.13.8651-8654.2005","article-title":"Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract","volume":"79","author":"Wright","year":"2005","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1093\/jpids\/piae017","article-title":"A Review of Respiratory Syncytial Virus Epidemiology Among Children: Linking Effective Prevention to Vulnerable Populations","volume":"13","author":"Daniels","year":"2024","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.4049\/jimmunol.1800558","article-title":"Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation","volume":"201","author":"Rayavara","year":"2018","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Silva, G.S.D., Borges, S.G., Pozzebon, B.B., and Souza, A.P.D. (2024). Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges. Microorganisms, 12.","DOI":"10.3390\/microorganisms12112305"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Efstathiou, C., Zhang, Y., Kandwal, S., Fayne, D., Molloy, E.J., and Stevenson, N.J. (2024). Respir-atory syncytial virus NS1 inhibits anti-viral Interferon-\u03b1-induced JAK\/STAT signal-ing, by limiting the nuclear translocation of STAT1. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1395809"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Ouyang, Y., Liao, H., Hu, Y., Luo, K., Hu, S., and Zhu, H. (2022). Innate Immune Evasion by Human Respiratory Syncytial Virus. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.865592"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/CMR.00090-16","article-title":"The Human Immune Response to Respiratory Syncytial Virus Infection","volume":"30","author":"Russell","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jmv.20590","article-title":"Genetic diversity among respiratory syncytial viruses that have caused repeated infections in children from rural India","volume":"78","author":"Parveen","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/cc4984","article-title":"Extrapulmonary manifestations of severe respiratory syncytial virus infection\u2014A systematic review","volume":"10","author":"Eisenhut","year":"2006","journal-title":"Crit. Care"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/pir.35.12.519","article-title":"Respiratory syncytial virus infection and bronchiolitis","volume":"35","author":"Piedimonte","year":"2014","journal-title":"Pediatr. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13052-025-01844-9","article-title":"Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection","volume":"51","author":"Manti","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Huang, L., Ye, C., Zhou, R., and Ji, Z. (2024). Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: A retrospective study. BMC Pediatr., 24.","DOI":"10.1186\/s12887-024-04822-y"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Kubota, J., Hirano, D., Okabe, S., Yamauchi, K., Kimura, R., Numata, H., Suzuki, T., Kakegawa, D., and Ito, A. (2021). Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253532"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"De Rose, D.U., Maddaloni, C., Martini, L., Braguglia, A., Dotta, A., and Auriti, C. (2023). Comparison of three clinical scoring tools for bronchiolitis to predict the need for respiratory support and length of stay in neonates and infants up to three months of age. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1040354"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/jmv.24522","article-title":"Performance evaluation of four rapid antigen tests for the detection of Respiratory syncytial virus","volume":"88","author":"Jung","year":"2016","journal-title":"J. Med. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jped.2016.06.013","article-title":"Rapid antigen detection test for respiratory syncytial virus diagnosis as a diagnostic tool","volume":"93","author":"Mesquita","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e01777-17","DOI":"10.1128\/JCM.01777-17","article-title":"Multicenter Clinical Evaluation of the Alere i Respiratory Syncytial Virus Isothermal Nucleic Acid Amplification Assay","volume":"56","author":"Hassan","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Lin, C.Y., Hwang, D., Chiu, N.C., Weng, L.C., Liu, H.F., Mu, J.J., Liu, C.P., and Chi, H. (2020). Increased Detection of Viruses in Children with Respiratory Tract Infection Using PCR. Int. J. Environ. Res. Public. Health, 17.","DOI":"10.3390\/ijerph17020564"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/INF.0b013e318157da6f","article-title":"Diagnostic assays for respiratory syncytial virus disease","volume":"26","author":"Henrickson","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/infdis\/jiad185","article-title":"Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis","volume":"228","author":"Onwuchekwa","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/22221751.2021.1873073","article-title":"Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A\/B, and respiratory syncytial virus using the BD MAX open system","volume":"10","author":"Chung","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"105402","DOI":"10.1016\/j.jcv.2023.105402","article-title":"Rapid differential diagnosis of SARS-CoV-2, influenza A\/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay","volume":"161","author":"Domnich","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jmv.25674","article-title":"Recent advances in the detection of respiratory virus infection in humans","volume":"92","author":"Zhang","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/14737159.2024.2408745","article-title":"Multiplex molecular assays for the laboratory-based and point-of-care diagnosis of infections caused by seasonal influenza, COVID-19, and RSV","volume":"24","author":"Domnich","year":"2024","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"105693","DOI":"10.1016\/j.jcv.2024.105693","article-title":"Analytical and clinical validation of a novel, laboratory-developed, modular multiplex-PCR panel for fully automated high-throughput detection of 16 respiratory viruses","volume":"173","author":"Tang","year":"2024","journal-title":"J. Clin. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00044067-200208000-00008","article-title":"Management of respiratory syncytial virus with lower respiratory tract infection in infants and children","volume":"13","author":"Garzon","year":"2002","journal-title":"AACN Clin. Issues"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/eri.10.140","article-title":"Respiratory syncytial virus disease: Update on treatment and prevention","volume":"9","author":"Krilov","year":"2011","journal-title":"Expert. Rev. Anti-Infect. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Kimberlin, D.W., Barnett, E.D., Lynfield, R., and Sawyer, M.H. (2021). Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases, American Academy of Pediatrics.","DOI":"10.1542\/9781610025225"},{"key":"ref_91","first-page":"94","article-title":"Respiratory Syncytial Virus Bronchiolitis in Children","volume":"95","author":"Smith","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1573396318666220810161945","article-title":"Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review","volume":"19","author":"Hon","year":"2023","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","article-title":"Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: A systematic review and meta-analysis","volume":"29","author":"Manothummetha","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Gong, X., Luo, E., Fan, L., Zhang, W., Yang, Y., Du, Y., Yang, X., and Xing, S. (2024). Clinical research on RSV prevention in children and pregnant women: Progress and perspectives. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1329426"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(24)01699-4","article-title":"Respiratory syncytial virus vaccination and immunoprophylaxis: Realising the potential for protection of young children","volume":"404","author":"Pecenka","year":"2024","journal-title":"Lancet"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.7150\/ijbs.64762","article-title":"Respiratory syncytial virus: From pathogenesis to potential therapeutic strategies","volume":"17","author":"Shang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5144\/0256-4947.2021.31","article-title":"Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease","volume":"41","author":"Mohammed","year":"2021","journal-title":"Ann. Saudi Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12360","article-title":"Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: A systematic review and economic evaluation","volume":"12","author":"Wang","year":"2008","journal-title":"Health Technol. Assess."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2140533","DOI":"10.1080\/21645515.2022.2140533","article-title":"RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003\u20132020","volume":"18","author":"Packnett","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"See, K.C. (2023). Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians. Vaccines, 11.","DOI":"10.3390\/vaccines11121809"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"209","DOI":"10.15585\/mmwr.mm7309a4","article-title":"Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season\u2014New Vaccine Surveillance Network, October 2023\u2013February 2024","volume":"73","author":"Moline","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2365804","DOI":"10.1080\/21645515.2024.2365804","article-title":"Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain","volume":"20","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s40121-024-01037-7","article-title":"Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes","volume":"13","author":"Kieffer","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/13696998.2023.2242169","article-title":"Immunization, not vaccination: Monoclonal antibodies for infant RSV prevention and the US vaccines for children program","volume":"26","author":"Sevilla","year":"2023","journal-title":"J. Med. Econ."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay, S., Manolaridis, I., Warren, C., Tang, A., O\u2019Donnell, G., Luo, B., Staupe, R.P., Vora, K.A., and Chen, Z. (2025). Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus. Vaccines, 13.","DOI":"10.3390\/vaccines13010035"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: The vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100379","DOI":"10.1016\/j.jvacx.2023.100379","article-title":"Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study","volume":"15","author":"Willemsen","year":"2023","journal-title":"Vaccine X"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40121-024-01000-6","article-title":"Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan","volume":"13","author":"Ishiwada","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-020-0163-z","article-title":"Modified mRNA\/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection","volume":"5","author":"Espeseth","year":"2020","journal-title":"npj Vaccines"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Topalidou, X., Kalergis, A.M., and Papazisis, G. (2023). Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines. Pathogens, 12.","DOI":"10.3390\/pathogens12101259"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2022.10.001","article-title":"Development of mRNA vaccines against respiratory syncytial virus (RSV)","volume":"68","author":"Qiu","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"ref_117","first-page":"177","article-title":"Overview of bronchiolitis","volume":"26","author":"Chehab","year":"2005","journal-title":"Saudi Med. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/jpc.16197","article-title":"Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions","volume":"58","author":"Binns","year":"2022","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1651-2227.2007.00458.x","article-title":"Lung Function and Bronchial Hyper-Responsiveness 11 Years after Hospitalization for Bronchiolitis","volume":"96","author":"Reijonen","year":"2007","journal-title":"Acta Paediatr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1034\/j.1399-3038.2000.00068.x","article-title":"Inhaled Corticosteroids during and after Respiratory Syncytial Virus-Bronchiolitis May Decrease Subsequent Asthma","volume":"11","author":"Kajosaari","year":"2000","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Meier, K., Riepl, A., Voitl, P., Lischka, L., Voitl, J., Langer, K., Kuzio, U., Redlberger-Fritz, M., and Diesner-Treiber, S. (2024). Characterisation of RSV Infections in Children without Chronic Diseases Aged 0-36 Months during the Post-COVID-19 Winter Season 2022\/2023. Front. Pediatr., 12.","DOI":"10.3389\/fped.2024.1342399"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/11\/3880\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:44:27Z","timestamp":1760031867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/11\/3880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":121,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14113880"],"URL":"https:\/\/doi.org\/10.3390\/jcm14113880","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}